Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen and Scripps Research Institute to Co-Develop Methods for Studying Membrane Proteins

NEW YORK, Aug. 26 (GenomeWeb News) - Invitrogen and the Scripps Research Institute are collaborating on new methods to study membrane proteins, the two partners said yesterday.

 

Under the direction of Geoffrey Chang, a group leader at Scripps, scientists at Scripps and Invitrogen's proteomics R&D group will try to develop better ways to express, isolate, and characterize membrane proteins.

 

Invitrogen will have the right to commercialize resulting technologies in the research and drug-screening markets.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.